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Plantar fasciitis is a common cause of heel pain. It has been suggested that some acupoints have a speciﬁc eﬀect on heel pain.
The aim of this study was to determine the eﬃcacy and speciﬁcity of acupuncture treatment for plantar fasciitis. Subjects were
randomly assigned to the treatment group (n = 28) or control group (n = 25). The treatment group received needling at the
acupoint PC 7, which is purported to have a speciﬁc eﬀect for heel pain. The control group received needling at the acupoint
Hegu (LI 4), which has analgesic properties. Treatment was administered ﬁve times a week for 2 weeks, with an identical method
of manual needling applied to the two acupoints. The primary outcome measure was morning pain on a 100-point visual analog
scale (VAS) at one month post-treatment. Secondary outcome measures included a VAS for activity pain, overall pain rating as
well as pressure pain threshold using algometry. Signiﬁcant diﬀerences in reduction in pain scores, favoring the treatment group,
were seen at one month for morning pain (22.6 ± 4.0 versus 12.0 ± 3.0, mean ± SEM), overall pain (20.3 ± 3.7 versus 9.5 ± 3.6)
and pressure pain threshold (145.5 ± 32.9 versus −15.5 ± 39.4). No serious adverse event was observed in either group. The results
indicate that acupuncture can provide pain relief to patient with plantar fasciitis, and that PC 7 is a relatively speciﬁc acupoint for
heel pain.
1.Introduction
Heel pain aﬀects about 10% of the general population
and it is commonly caused by plantar fasciitis [1]. Plantar
fasciitis is characterized by pain and tenderness centered on
the medial tubercle of the calcaneum on weight bearing,
especially immediately after rest such as getting out of bed
in the morning [2]. The etiology of the disease is unclear.
Current conventional treatments include the use of non-
steroidal anti-inﬂammatory drugs and steroid injections [3],
but these drug treatments may be associated with serious
side-eﬀects [4], and an exploration of alternative treatments
is thus warranted.
Acupuncture has been used for many musculoskeletal
pain conditions, including heel pain. A thorough literature
survey in both Chinese and English electronic databases,
including PUBMED, AMED and VIP (a database of Chinese
scientiﬁc and technological journals), as well as journals of
complementary medicine, such as eCAM, up to 2005, iden-
tiﬁed articles related to acupuncture treatment for heel pain
[5]. Only two studies published in Chinese were controlled
clinical trials that used acupuncture treatment alone as one
of the intervention groups [6, 7]. However, the results from
these were controversial, as one of the studies reported that
acupuncturetreatmentwasbetterthanlocalsteroidinjection
[7], whereas the other reported the opposite [6]. In addition,
basedoncurrentreportingstandards[8],bothstudieslacked
scientiﬁc rigor and we concluded that further research was
necessary to establish the eﬃcacy of acupuncture treatment
for heel pain.
A number of mechanisms have been proposed to explain
the pain-relieving eﬀect of acupuncture, including central
opioid pain inhibition [9], diﬀuse noxious inhibitory control
(DNIC) system [10] and anti-inﬂammation [11, 12]. Pre-
sumably, insertion of a needle at any part of the body may
alleviate pain by the mechanisms of opioids or DNIC [9,
13], and the anti-inﬂammatory action of acupuncture may
be generalized across the body. Therefore, a fundamental
questionoftenaskediswhetherneedlesmustbeinsertedinto
speciﬁc sites to produce the best eﬀect. Despite the obvious
importance of this question, only a few clinical studies have
succeeded in demonstrating the speciﬁcity of an acupoint in2 Evidence-Based Complementary and Alternative Medicine
pain-related conditions [14, 15] in contrast to a majority of
studies showing acupoint speciﬁcity in non-pain conditions
[16–20].
There are many diﬃculties in designing clinical trials
to demonstrate the speciﬁcity of acupoints. For example,
acupuncture treatment often involves multiple acupoints,
thus it is not possible to isolate the therapeutic eﬀect to a
single acupoint, even though there may be a speciﬁc eﬀect
for a group of acupoints. Furthermore, since the mechanism
of acupuncture is not clear, an arbitrary chosen control-
acupoint or non-acupoint may in fact produce the same
physiological responses as the test-acupoint, and thus it may
have the same eﬀectiveness as the test-acupoint. Therefore,
in order to examine the speciﬁcity of acupoints, it would be
desirable to study those treatments using a single acupoint
that has a distinct mechanism of action.
For acupuncture treatment of heel pain, two treatment
approaches are commonly used: local acupoints or a single
distal acupoint [21–24]. The use of a single distal acupoint
in treatment of heel pain provides a unique opportunity
to study acupoint speciﬁcity, even though the mechanism
underlying the treatment is still unclear. In this study, we
assessed the speciﬁcity of the acupoint Daling (PC7) for heel
pain, using a nearby acupoint Hegu (LI4) as control. PC7
is used for pain conditions including stomachache, chest or
cardiac pain and headache, in additional to heel pain; LI4
has well-known analgesic properties and is commonly used
for dental pain, headache and general analgesia [25, 26]. We
used identical methods of needling at both PC7 and LI4. The
hypothesis being tested was that PC7 had a better eﬀect than
LI4 in relieving pain due to plantar fasciitis. If PC7 were
indeed more eﬀective than LI4, it would suggest that PC7
not only has a speciﬁc eﬀect for heel pain, but also has a
mechanism of action diﬀerent from that observed for LI4.
2. Methods
2.1. Patient Recruitment. This study was approved by the
Committee on the Use of Human and Animal Subjects in
Teaching and Research of the Hong Kong Baptist University,
and was conducted between 2005 and 2006. Announcements
about the study were made in local newspapers and various
community centres, and prospective patients were invited
to an information session, during which the study was
explained. They were informed prior to randomization that
thepurposeofthestudywastoevaluatetheeﬀectofaspeciﬁc
type of acupuncture for heel pain, and that they would
be allocated to either the treatment group or the control
group. Initial participant screening involved obtaining a
clinical history, examination of the lower limb and recording
baseline measurements. These were performed immediately
after the information session.
2.2. Randomization. Randomization occurred on the day
participants returned for their ﬁrst treatment, somewhere
between 5 and 14 days after the initial screening. Using
computer generated random numbers, participants were
randomized into either the treatment group or the control
group. Both the participant and the researcher who obtained
the measurements were blinded to the group status of the
participant. A coding system was used by the acupuncturist
(TPY) to identify the group status to enable the administra-
tion of the corresponding treatment.
2.3. Inclusion Criteria. Adult participants aged ≥18 years
with heel pain for >3 months preceding the study were
included. Participants were diagnosed as having plantar
fasciitis if the pain was localized to the medial tubercle of the
calcaneum, which is the site of the insertion of the plantar
fasciaandintrinsicmusclesofthefoot[2].Theywereadvised
to abstain from other forms of treatment during the study
period, with informed use of analgesics only if absolutely
necessary.
2.4. Exclusion Criteria. We excluded participants with a his-
tory of fracture or dysfunction of the ankle or knee, or
arthritis; with signs of nerve injury; with severe systemic
diseases, such as rheumatoid arthritis, diabetes or cardio-
vascular disorder; who were unlikely to attend all treatment
sessions or who were needle phobic, pregnant or breast
feeding.
2.5. Acupuncture Treatment. T h ep r o t o c o lf o rt h ea c u p u n c -
ture treatment was based on previous clinical reports [23,
24]. Participants in the treatment group received needling at
the acupoint Daling (PC7), which is located on the palmar
side of the forearm at the midpoint of the wrist crease
[27]. Participants in the control group received needling
at the acupoint Hegu (LI4), which is located between the
ﬁrst and second metacarpal bones [28]. LI4 was chosen
as the control point because it was close to PC7 and had
analgesic properties [25, 26]. Needling was performed at
PC7 or LI4 on the contralateral side to the heel pain.
If the heel pain was on both sides, bilateral needling of
either PC7 or LI4 was performed. Both PC7 and LI4
acupoints were stimulated using sterile acupuncture needles,
15mm long with a diameter of 0.25mm (Huatuo, Suzhou
Medical Instruments Factory, Suzhou, China). Needles were
inserted perpendicularly with the aid of a guide tube,
advanced ∼10mm deep using slight rotation and thrusting
to obtain the Deqi sensation, which was reported by the
participants as a dull ache, numbness or heaviness. Needle
manipulation was repeated approximately every 5min to
maintain the Deqi sensation, and each treatment session
lasted for 30min. The needling procedures were identical
for both the treatment and control groups. Both groups
received 10 daily treatment sessions over a 2-week period
(usually Monday–Friday). Needlings were performed by a
registered Chinese medicine practitioner with 2 years of
clinical experience. The practitioner (TPY) had been trained
to carry out the treatment procedures as stipulated in the
protocol.
2.6. Assessments. Initial patient screening involved taking a
detailedhistoryandaphysicalexaminationofthelowerlimb.
A blinded assistant completed the case report form for theEvidence-Based Complementary and Alternative Medicine 3
patient at each treatment visit and at the one month follow-
up. A questionnaire was posted to participants to follow-up
at 3 and 6 months post-treatment. If no reply was received
after a week, a telephonic interview was conducted to collect
the data.
In order to assess the credibility of the control treatment,
the participants’ beliefs about the treatment were assessed
using a modiﬁed Borkovec and Nau scale [28]. At the
beginning of the ﬁrst treatment session and post last
treatment session participants were asked to answer four
questionsonasix-pointscale:(i)“Howconﬁdentdoyoufeel
that this treatment can alleviate your complaint?”; (ii) “How
conﬁdent would you be in recommending this treat-
ment to a friend who suﬀered from similar complaints?”;
(iii) “How logical does this treatment seem to you?” and
(iv) “How successful do you think this treatment would be
in alleviating other complaints?”. Furthermore, participants’
perception of acupuncture stimulation was assessed using
a questionnaire that had been previously used [29], with
modiﬁcations so that it could be used at the end of each
treatment session. Thus, prior to the administration of the
questionnaire participants were informed about the concept
of Deqi, a sensation that occurs with needling, which was
deﬁned as the feeling of numbness, dull ache, heaviness or
a radiating sensation. At the end of each treatment session,
they were asked to indicate the intensity (on a 100-point
visual analog scale, VAS) and duration of the Deqi sensation.
In addition, participants were asked to record their overall
perception of needling pain using a VAS.
2.7. Outcome Measures. Morning pain is a distinct feature
of plantar fasciitis, and thus has been used as the primary
outcome measure. Participants were asked to record their
perception of heel pain on a 100-point VAS with descriptors
at either end (0 no pain; 100 maximal pain). Secondary
outcome measures were activity pain (heel pain during
activity) and the overall perception of heel pain. Pressure
pain threshold was measured using an electronic algometer
(SOMEDIC, Sweden) applied by a trained researcher (QSL),
prior to each treatment session. Algometry involved a 1cm2
probe placed at the medial tubercle of the calcaneum of
the non-painful foot, and at the most painful site on the
painful foot (usually the medial tubercle of the calcaneum).
The maximum force that could be applied was limited to
1000kPa for practical reasons. A mean score was obtained
from three repeated measurements. Any participant who
reported an adverse reaction was noted. Non-study treat-
ments received by participants before, during and after the
treatment were also recorded.
2.8. Statistical Analysis. For sample size estimation, we pre-
sumed that the means and standard deviations of the VAS
scores in the control and treatment groups were the same,
and were similar to those previously reported [30]. Thus,
the respective mean VAS scores and the standard deviations
were assumed to be 50 and 20 on a 100-point scale. As a
33–36% improvement had been considered to be of clinical
importance in pain outcome measures [31], we intend to
detect a 16.5 unit (33%) diﬀerence between the treatment
and control groups. With the level of signiﬁcance set at
0.05 and the power at 80%, a sample size of 50 would be
required. Allowing for a dropout rate of 20%, the number
of participants required was estimated to be 62.
For data analysis, the SPSS software (version 13) was
used. Data were analyzed using Student’s t-test, Chi-square
test, analysis of variance and covariance with Bonforroni
correction and regression analysis, as appropriate.
3. Results
3.1. Participants. Of the 89 subjects who participated in
the screening, 62 met the inclusion criteria. Reasons for
exclusion were: the onset of heel pain was<3 months (n = 2),
pain was not located at the heel (n = 14), history of foot
injury (n = 3), rheumatoid arthritis (n = 2), unable to attend
all treatment sessions (n = 3), signs of nerve injury (n = 2)
and pain in multiple locations of the body with an unknown
diagnosis(n =1).Afterthescreening,nineparticipantsfailed
to return for treatment without giving a reason. Altogether,
53 participants were randomized, with 28 allocated to the
treatment group that received needling at PC7, and 25 to the
control group that received needling at LI4. Two participants
later withdrew from the study in the LI4 group, one after
the ﬁrst treatment session due to intolerance towards the
pain associated with the treatment, and the other one after
the third treatment session because the heel pain was not
improving. In total, 28 participants in the PC7 group and 23
in the LI4 group completed the 10 treatment sessions. Five
participants were lost to some of the follow-ups (Figure 1).
At the end of the 6-months period, follow-up data were
obtained from 25 participants in the PC7 group and 22
in the LI4 group (Figure 1). To determine the diﬀerence
in treatment outcomes between the two groups, intention-
to-treat analysis was carried out with missing data being
replaced by the last value carried forward.
3.2. Baseline Characteristics. The general characteristics of
the participants are listed in Table 1. It can be seen that
most participants were women (71% in PC7 and 76% in LI4
group) and had bilateral heel pain (54% in PC7 and 52%
in LI4 group). We asked participants to bring in their X-
ray ﬁlms, if available, and identiﬁed the presence of calcaneal
spurin28%ofparticipantsinthePC7group(n=8)and24%
in the LI4 group (n = 6). Most participants were receiving
some form of treatments prior to entering the trial, but
no patient had previously received surgery for heel pain.
For both groups of participants, pressure pain thresholds at
the painful foot were signiﬁcantly lower than at the non-
painful foot (P < .05). The duration of heel pain in the
PC7 group ranged from 3 to 216 months, and in the LI4
group ranged from 3 to 144 months, with no statistical
signiﬁcant diﬀerence in the mean durations between the two
groups (P > .05). A negative correlation was found between
the duration of heel pain and the morning pain score (r =
–0.351, P = .0132, n = 53), suggesting that morning pain
decreased as the duration of heel pain increased. Overall,4 Evidence-Based Complementary and Alternative Medicine
Assessment for eligibility (n = 89)
Not meeting the
inclusion criteria (n = 27)
Not showing up
for treatment (n = 9)
Randomized patients (n = 53)
Treatment
PC 7 (n = 28) LI 4 (n = 25)
Withdrawals
(n = 2)
Follow-up
1st month (n = 25)
3rd month (n = 28)
6th month (n = 25)
1st month (n = 21)
3rd month (n = 23)
6th month (n = 22)
Figure 1: CONSORT chart of the clinical trial process.
no signiﬁcant diﬀerence existed in the baseline data between
the two groups. During the intervention period, no subject
reported the use of other treatments.
3.3. Changes in Outcome Measures. For the PC7 group, com-
pared with the baseline value, a signiﬁcant improvement in
morning pain was observed from one month post-treatment
to the 6-month period (P < .001, ANOVA with Bonferroni
post-hoc test). For the secondary outcome measures, gradual
improvementsfrombaselinevalueswereseeninactivitypain
and overall pain following the seventh treatment session
and continuing up to 6 months (P < .05), except that
changes were not signiﬁcant at the eighth treatment session
and at one month post-treatment (P > .05). The changes
in pressure pain threshold were not statistically signiﬁcant
compared with the baseline. A negative correlation between
the duration of heel pain and the eﬀect of the PC7
treatment in morning pain was found (r = –0.399, P = .039,
n = 28), suggesting that the treatment was more eﬀective for
participants who reported a shorter duration of heel pain. In
contrast, the LI4 group showed no improvement in morning
pain. The only signiﬁcant improvements for this group were
activity pain and overall pain at 6 months (P < .05, ANOVA
with Bonferroni post-hoc test). Furthermore there appeared
to be a rebound eﬀect at one month post-treatment in the
control group (Figure 2).
Ofprimary interest is whetherthere wasanydiﬀerence in
the improvements between the PC7 and LI4 groups. Using a
multivariate general linear model in the SPSS software with
baseline values as covariate and applying Bonferroni cor-
rection, signiﬁcant diﬀerences were detected at one month
for morning pain (P = .044), overall pain (P = .049) and
pressure pain threshold (P = .007), favoring the PC7 group.
Table 1: Demographic and baseline data.
Characteristic Mean ± SEM; n (%)
PC7 (n = 28) LI4 (n = 25)
Age (years) 47.0 ± 2.2 50.0 ± 2.0
Height (cm) 161.4 ± 1.8 159.2 ± 2.3
Weight (kg) 64.8 ± 2.3 66.7 ± 2.6
Sex
Male 8 (28.6) 6 (24)
Female 20 (71.4) 19 (76)
Aﬀected side
Left 7 (25) 7 (28)
Right 6 (21.4) 5 (20)
Bilateral 15 (53.6) 13 (52)
Duration of heel pain (months) 44.9 ± 8.8 22.9 ± 8.8
Weight bearing time (h/day) 5.8 ± 0.7 4.6 ± 0.6
Calcaneal spur shown in X-ray 8 (28.6) 6 (24)
Not receiving any treatment 2 (7.1) 4 (16)
Previous treatments 26 (92.9) 21 (84)
Western medicine 13 14
Local injections 4 5
Surgery 0 0
Chinese medicine 10 7
Acupuncture 12 4
Physiotherapy 11 7
Foot pad 18 13
Cream or tape 15 0
Others 1 0
Morning pain (a) 55.3 ± 4.6 53.2 ± 4.7
Activity pain (a) 54.5 ± 3.1 48.3 ± 4.1
Overall pain (a) 58.1 ± 2.6 55.0 ± 3.4
Pain threshold (kPa)
Normal foot 835.2 ± 34.6 873.9 ± 35.3
Aﬀected foot 466.9 ± 34.0 522.7 ± 48.4
(a)0–100 point scale.
Diﬀerenceinactivitypainwasalsoobservedat6months(P =
.048; Figure 2). The diﬀerences in improvements of outcome
measures between the two groups are also summarized in
Figure 3 to illustrate the eﬀect size of treatment.
3.4. Perception of Acupuncture Stimulation and Credibility
Rating. Participants’ perception of Deqi sensation and pain
associated with acupuncture treatment are summarized in
Figure 4. There was no diﬀerence in the duration and
intensityofDeqisensationorintheintensityofpainbetween
the two groups. Thus, the perception of the acupuncture
stimulation appeared to be similar for the two groups.
The results of Borkovec and Nau scale used to assess
credibility are shown in Figure 5. It can be seen that there
was no diﬀerence in the score of each question before the
treatment sessions between the two groups. For the PC7
group, there was no diﬀerence in the scores before and
after the treatment sessions. However, for the LI4 group,
the score for the question of “How successful do you thinkEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: (a)–(d) Line graphs showing the eﬀects of acupuncture treatment at two diﬀerent acupoints. Patients were randomized into
the treatment group (n = 28), receiving acupuncture at acupoint PC7 (diamonds), and the control group (n = 25), receiving acupuncture at
acupointLI4(squares).Valuesaremean ±SEMtakenatdiﬀerenttimepoints.T0,justpriortotheﬁrsttreatment;T1,aftertheﬁrsttreatment
and just prior to the second treatment; T9, after the ninth treatment just prior to the tenth treatment; 1M, 1 month post-treatment; and
so forth. Crosses and empty triangles indicate statistical signiﬁcant diﬀerences compared with T0 in the PC7 group and the LI4 group,
respectively (P < .05; one-way ANOVA with Bonferroni post hoc test). Stars indicate statistical signiﬁcant diﬀerences between the PC7 and
LI4 groups at a given time point using a multivariate general linear model, with baseline values as covariate (P < .05, with Bonferroni
correction).
this treatment would be in alleviating other complaints”
was increased after the treatment sessions, which was also
signiﬁcantly higher than that of the PC7 group. In other
words, participants in the LI4 group became more conﬁdent
in acupuncture for alleviating other complaints towards the
end of the treatment course. When the results of perception
of acupuncture stimulation and credibility rating taken
together,itwasapparentthatneedlingacupointLI4hadbeen
perceived by the participants as a highly credible form of
treatment in the current experimental setting.
3.5. Adverse Reaction. No severe adverse reaction was seen in
eithergroup.Onepatientwithdrewfromthetreatmentinthe
LI4 group because the treatment was too painful. A total of 8
participants (28.6%) in the PC7 group and 10 (40%) in the
LI4 group reported mild adverse reactions other than pain.
Speciﬁcally, mild local edema around the area of needling
was the second most common reaction next to pain (PC7:
n = 2; LI4: n = 7). Bruising was the third most common
adverse eﬀect(PC7: n = 4; LI4: n = 5). One patient in the PC7
group reported a distressed sensation in the chest on three
occasions.
4. Discussion
This is the ﬁrst study investigating the eﬃcacy of a single
acupoint for plantar fasciitis, and one of few studies that
examines the speciﬁcity of a single acupoint for chronic
pain. We found statistical diﬀerences in the primary and
secondaryoutcomemeasuresbetweenthePC7groupandthe
LI4groupprimarilyattheonemonthpost-treatmentperiod.
Our ﬁndings suggest that relative to LI4, acupoint PC7 has
speciﬁc eﬀect on heel pain due to plantar fasciitis.
In acupuncture treatment, four major factors may con-
tribute to the improvement of symptoms: the spontaneous
resolution of the condition, the placebo or psychological
eﬀectthat is similar to that observed in participants receiving
placebo medication, a general or non-speciﬁc physiological
reaction to needling irrespective of site, and ﬁnally, a speciﬁc
eﬀect due to needling at an appropriate location [32].6 Evidence-Based Complementary and Alternative Medicine
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No diﬀerence was found between the two groups.
Depending on the research question being addressed, diﬀer-
entcontrolmethodshavepreviouslybeenused.Forexample,
to answer the question of whether acupuncture treatment
is better than no acupuncture treatment, non-stimulating
techniques, including “placebo” needle or non-insertion
of needle, sham laser and sham transcutaneous electrical
nerve stimulation (TENS), have been used as controls. To
determine whether needling of the intended sites is better
than needling of irrelevant sites, inserting the needles to
“inappropriate” points with intensity of stimulation similar
to the real treatment would be the choice of control. This
method of control has been used to study several pain
conditions, including low back pain [15], ﬁromyalgia [33]
and post-operative pain [14], but contradicting results have
been found with regards to the importance of needling
location. Furthermore, recent large-scale clinical trials found
that minimal acupuncture (superﬁcial needling) at “inap-
propriate” points had the same eﬃcacy as acupuncture at
intended points for headache [34], low back pain [35]a n d
migraine [36]. However, another study in patients with
osteoarthritis of the knee found pain and joint function
were improved more with acupuncture at intended points
than with minimal acupuncture at “inappropriate” points or
no acupuncture after 8 weeks of treatment [37]. Using an
“inappropriate” point with similar intensity of stimulation
as control, the present study found that the acupoint PC7
was more eﬀective than the “inappropriate” acupoint LI4
for heel pain. There are a few major diﬀerences between the
present study and those studies that fail to ﬁnd acupoint
speciﬁcity. For example, we compared one distal acupoint
with another “inappropriate” distal acupoint, whereas pre-
vious studies compared multiple intended acupoints with
multiple “inappropriate” acupoints, some of which were
located in the proximity of the diseased region. Since the
local “inappropriate” acupoints may produce similar neu-
rophysiological responses as the nearby intended acupoints
by means of segmental reﬂex response, they may have
a similar eﬃcacy as the appropriate points. Furthermore,
heel pain of plantar fasciitis is a homogenous pathological
condition characterized by local inﬂammation. Although we
used pain perception as outcome measures, the slow onset
and long-lasting eﬀect of pain reduction suggest that the
improvementsobservedinthecurrentstudyweremorelikely
duetoresolutionoftheunderlyinginﬂammationortheanti-
inﬂammatory eﬀect of acupuncture, rather than inhibitionEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Credibility assessment of acupuncture treatments using a six point Borkovec and Nau scale. (a) How conﬁdent do you feel that
this treatment can alleviate your complaint? (b) How conﬁdent would you be in recommending this treatment to a friend who suﬀered from
similar complaints? (c) How logical does this treatment seem to you? (d) How successful do you think this treatment would be in alleviating
other complaints? (∗P < .05; PC7: n = 28, LI4: n = 25).
of pain processing or an immediate analgesic eﬀect. Taken
together, it is conceivable that diﬀerent mechanisms are
involved in acupuncture treatment of diﬀerent pain condi-
tions, and the eﬀect observed for PC7 in treatment of heel
pain is related to an anti-inﬂammatory action, rather than
an analgesic action, which has been observed previously for
LI4 [25, 26].
A drawback of this study is that it does not include a
second control arm, in which participants do not receive
any active acupuncture treatment. Thus we were not able
to assess the eﬃcacy of the intended acupuncture treatment
compared with placebo. In the current study, the diﬀerences
between the treatment and control groups in morning pain,
activity pain and overall pain were around 10–12 points on
a 100-point VAS scale (Figure 3), or about 20% of the 50–
60 baseline pain values. These diﬀerences do not reach the
33% threshold pre-deﬁned as having clinical signiﬁcance at
the beginning of this study. However, the control group also
showed gradual improvements from the baseline, although
most of these improvements were not statistically signiﬁcant.
The gradual improvement may be related to the eﬀects of
non-speciﬁc physiological responses evoked from needling
LI4, or due to spontaneous resolution of the condition. If
we determined the eﬀect size of the treatment based on the
diﬀerences between the PC7 and LI4 groups, the possible
non-speciﬁc physiological responses evoked from LI4 would8 Evidence-Based Complementary and Alternative Medicine
lead to underestimation of the eﬃcacy of PC7. A further
study should be carried out to determine the eﬃcacy of PC7
using a parallel non-treatment control group.
Nevertheless,apositiveconclusioncanbemadefromthis
study regarding the eﬃcacy of acupuncture if one views the
results from the patient’s prospective. That is, the baseline
morning pain was reduced by 22.6 points from a base line
of 55.3 points at one month follow-up in the PC7 group
(Figure 3). This represents a 40% reduction of pain from
the baseline, which would be of signiﬁcance to the patient
[31]. Therefore, though the study failed to demonstrate any
clinically signiﬁcant diﬀerence between the two groups, our
ﬁndings do suggest that participants receiving treatment
at acupoint PC7 would experience clinically relevant pain
reduction from one month onwards, although such relief
may be due to a combination of factors, such as the speciﬁc
eﬀect of PC7, non-speciﬁc physiological and psychological
responses and the spontaneous resolution of the disease.
In contrast, in the LI4 group such clinical relevant pain
reduction could only be found 6 months after the treatment.
In studies of steroid treatments for plantar fasciitis,
Gudemen showed a diﬀerence in the Merryland Foot Score
favoring dexamethasone at 2-3 weeks but not at one month,
when comparing the eﬀects of an inotophoretic application
of dexamethasone and saline [38]. In comparing steroid
injection with saline control injection, Crawdford reported
that the weighted mean diﬀerence in heel pain was 1.94
on the 10cm VAS score at one month but no signiﬁcant
diﬀerence thereafter [3]. Our study also found that most of
the signiﬁcant diﬀerences in outcome measures between the
treatment and control groups fell on the one month follow-
up, suggesting that both steroid injection and acupuncture
treatment share a similar time course of maximal eﬀec-
tiveness. It is not possible to compare the eﬃcacies of the
current speciﬁc acupuncture treatment with that of the
steroid injection, as the controls and other aspects of the two
trials are quite diﬀerent. It would be worthwhile, however,
in future studies to compare the eﬃcacies of acupuncture
treatment and steroid injection.
Although most of the statistical signiﬁcant diﬀerences
between the two groups were found at one month post-
treatment, statistically signiﬁcant improvements from the
baseline were seen in the treatment group after the seventh
treatment session for activity pain and morning pain. This
time course of treatment eﬀect is in agreement with previous
clinical reports showing that pain relief from acupuncture
canbe seen as early as 1-2 treatment sessions [39, 40].On the
other hand, there were few statistical diﬀerences between the
two groups at the 3 and 6 months post-treatment periods.
This may be due to the small sample size of the current
study, the self-limiting nature of the disease or participants
receiving other modalities of treatment during the follow-up
period.
Although traditional acupuncture theory includes a
point selection principle of using points of the upper
extremity to treat disease of the lower extremity, and vice
versa, no speciﬁc acupoint has been proposed for treatment
of heel pain from this theory. The underlying mechanism
for the speciﬁc eﬀect observed is not at all clear. The slow
Thalamus
Inﬂammation,
tissue irritation
Stimulation from
speciﬁc acupoints
Sensitizing input Normalizing input
Figure 6: A hypothetical diagram illustrating the possible mech-
anism of acupuncture treatment for plantar fasciitis. Repeated
stimulation from inﬂammation and tissue irritation of the heel will
sensitize neurons in the thalamus and habituate them to a state
of hyperexcitability, leading to a state of chronic pain. Repeated
stimulation from speciﬁc acupoints will send input to the same
thalamic focus and normalize the excitability of hyperexcitable
neurons.
onset and gradual time course of the eﬀects appear to rule
out any important contribution of the endogenous opioid
system or the DNIC mechanism, as both mechanisms are
fast but short acting [9, 41]. In the Chinese literature there
are many examples of using individual distal acupoints for
pain or inﬂammation, such as the use of Yaotongdian (EX-
UE7) at the hand for acute low back pain, the use of
Er Bai (EX-UE2) at the lower arm for hemorrhoids and
the use of Quchi (LI 11) for refractory uraemic pruritus
[17, 27]. Our results support the purported theory that
there exist speciﬁc acupoints for the corresponding pain
or inﬂammatory conditions. It has been proposed that
prolonged or repeated stimulation habituates neurons in the
thalamus to a state of hyperexcitability, leading to a state
of chronic pain [42], and stimulation of speciﬁc acupoints
may adjust the excitability of hyperexcitable neurons in the
thalamic focus (Figure 6). In this regard, it is interesting to
note that the center of the wrist crease on the palmar side,
where PC7 is located, is an anatomical mirror site of the
heel. The exact reason for the possible corresponding eﬀect
is worthy of further investigation. Functional brain imaging
studies may provide insight into mechanisms of the neural
network underlying the speciﬁcity of acupoints [43].
Inconclusion,thisstudydemonstratesthatacupointPC7
has a speciﬁc eﬀect for treatment of plantar fasciitis, and
that the method of acupuncture treatment is both simple
and safe. Further studies comparing acupuncture treatment
with an inert placebo and conventional treatment as parallel
arms are recommended to further elucidate the eﬃcacy of
acupuncture treatment for heel pain.
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